CTSW represented the owners of the Memphis Redbirds, the Triple-A affiliate of the St. Louis Cardinals baseball team, in a sale of the business to Diamond Baseball Holdings (“DBH”), a venture recently formed by Endeavor Group Holdings, Inc. The transaction was a part of a plan whereby DBH acquired 10 minor league teams, including teams […]
CTSW represented Benuvia Holdings, LLC with the sale of Benuvia Manufacturing Inc., Benuvia Manufacturing, LLC, Benuvia Therapeutics LLC and Benuvia Therapeutics IP LLC. Benuvia Therapeutics markets Syndros, a U.S. FDA-approved cannabinoid drug and has a pipeline of clinical stage product candidates focused on rare diseases. The transactions are the latest in CTSW’s long history of […]
CTSW represented a licensee in obtaining the rights to manufacture, market, and sell nutraceutical and health foods in Australia. The product is endorsed by a movie celebrity and the agreement includes future promotional appearances. In addition to deep experience in pharmaceutical licensing agreements, CTSW has also represented numerous businesses and celebrities in endorsement and related […]
CTSW represented a New York-based Clinical Research Organization with a US-based sponsor for the conduct of a clinical trial in the European Union, including GDPR compliance requirements. Larry Tauber and Jerry Cohen worked on this transaction.
CTSW represented the seller of a $60 million Upper East Side triplex, the largest co-op transaction in Manhattan since 2015. The firm has represented purchasers and sellers of numerous high-end residential properties. Joe Vann, Larry Tauber, and Daniel Friedman worked on the transaction.
The latest in the firm's work with real estate developers and investors.
Discussing business partners, investors, intellectual property, and other concerns of early-stage businesses.
Covering real estate, employment, and other concerns.
The latest in the firm's work involving fine art and other esoteric assets.